.png){kind=icon}
.png){kind=icon}
Return
Efficacy of GLP-1 receptor agonists in patients with obesity and heart failure with preserved ejection fraction: A systematic review and meta-analysis of randomised controlled trials
.png){kind=icon}
PRE
AI
J
L
B
R
D
D
B
N
M
F
C
T
DOI：10.1111/dom.70102.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Obesity increases the risk of heart failure with preserved ejection fraction (HFpEF). Glucagon-like-peptide-1 receptor agonists (GLP-1 RAs) appear to improve cardiovascular outcomes in these patients; however, this benefit remains uncertain.
Keywords:
GLP-1 RAs
heart failure
HFpEF
obesity
Journal
D
IF:
5.7
Papers:
6.1K
Citations:
1.7W
Organization
Cited Papers